B, C., X, L., J, X., D, Z., Y, T., Z, X., . . . J, W. (2026). Discovery of Naphthyridinone Derivatives as Selective PKMYT1/WEE1 Dual Inhibitors for Cancer Therapy. Journal of medicinal chemistry, 69(9), 10380. https://doi.org/10.1021/acs.jmedchem.5c03521
Chicago Style (17th ed.) CitationB, Chen, et al. "Discovery of Naphthyridinone Derivatives as Selective PKMYT1/WEE1 Dual Inhibitors for Cancer Therapy." Journal of Medicinal Chemistry 69, no. 9 (2026): 10380. https://doi.org/10.1021/acs.jmedchem.5c03521.
MLA (9th ed.) CitationB, Chen, et al. "Discovery of Naphthyridinone Derivatives as Selective PKMYT1/WEE1 Dual Inhibitors for Cancer Therapy." Journal of Medicinal Chemistry, vol. 69, no. 9, 2026, p. 10380, https://doi.org/10.1021/acs.jmedchem.5c03521.
Warning: These citations may not always be 100% accurate.
